Body mass index and diabetes predict severity of liver fibrosis across the spectrum of steatotic liver disease
MetALD had the lowest prevalence and fibrosis severity among the three groups of SLD. Elevated BMI and DM were associated with the severity of liver disease, and these findings provide a rationale for the use of obesity- and diabetes-targeted medications in these individuals.
Authors
- Eda Kaya (ORCID: https://orcid.org/0000-0002-9293-2811)
- Eduardo Vilar‐Gómez (ORCID: https://orcid.org/0000-0003-1435-4013)
- Raj Vuppalanchi (ORCID: https://orcid.org/0000-0003-0637-1577)
- Yusuf Nadir Yilmaz (ORCID: https://orcid.org/0000-0003-4518-5283)
Institutions
- Recep Tayyip Erdoğan University (TR)
- Universitätsklinikum Knappschaftskrankenhaus Bochum (DE)
- Indiana University School of Medicine
- Indiana University – Purdue University Indianapolis (US)
Publication Details
- Journal
- Annals of Hepatology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1016/j.aohep.2025.101907
- Citations
- 5
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 6.77